tiprankstipranks
Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Holding ELUT?
Track your performance easily

Aziyo Biologics (ELUT) Financial Statements

59 Followers

Aziyo Biologics Financial Overview

Aziyo Biologics's market cap is currently ―. The company's EPS TTM is $-2.875; its P/E ratio is -1.68; Aziyo Biologics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 5.92M$ 6.29M$ 6.69M$ -4.73M$ 6.13M
Gross Profit$ 2.74M$ 2.80M$ 2.84M$ 901.00K$ 2.84M
EBIT$ 1.29M$ -27.10M$ -18.12M$ -13.72M$ -7.06M
EBITDA$ 2.21M$ -26.19M$ -17.20M$ -12.82M$ -6.11M
Net Income Common Stockholders$ 1.07M$ -28.18M$ -18.00M$ -9.29M$ -9.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.74M$ 18.19M$ 12.55M$ 19.28M$ 14.52M
Total Assets$ 48.41M$ 41.90M$ 35.36M$ 43.43M$ 54.58M
Total Debt$ 22.64M$ 22.32M$ 22.01M$ 23.68M$ 25.28M
Net Debt$ -3.10M$ 4.13M$ 9.46M$ 4.40M$ 10.76M
Total Liabilities$ 88.64M$ 106.24M$ 85.66M$ 82.03M$ 84.05M
Stockholders Equity$ -40.24M$ -64.34M$ -50.30M$ -38.60M$ -29.47M
Cash Flow-
Free Cash Flow$ -3.95M$ -4.40M$ -2.62M$ -9.10M$ -5.18M
Operating Cash Flow$ -3.40M$ -4.40M$ -2.60M$ -9.08M$ -5.12M
Investing Cash Flow$ -547.00K$ 182.00K$ -15.00K$ 14.54M$ -62.00K
Financing Cash Flow$ 11.53M$ 9.79M$ -4.07M$ -695.00K$ 10.41M
Currency in USD

Aziyo Biologics Earnings and Revenue History

Aziyo Biologics Debt to Assets

Aziyo Biologics Cash Flow

Aziyo Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis